IRLab Therapeutics CEO to Present at Neurology Event in Stockholm
1 report, 1 independent
Updated Oct 9
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
IRLab Therapeutics AB announced that CEO Kristina Torfgård will present the company at Redeye Theme: Neurology on October 15 in Stockholm. The company, which develops treatments for Parkinson's disease, will participate in the meeting with Swedish and international investors.
From pr-inside.com
Why it matters
The presentation offers the company opportunities to expand its network and establish new contacts with investors. IRLAB Therapeutics is developing compounds like Mesdopetam and Pirepemat for Parkinson's disease.
IRLab Therapeutics is headquartered in Sweden.
From pr-inside.com
Who's involved
- StockholmLocation of the investor presentation